Communicating Epidemiologic Information

Applied Epidemiology: Theory to Practice

Volumn , Issue , 2006, Pages

  Remington, Patrick L ^a   Nelson, David ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Communication strategies; Epidemiologists; Epidemiology; Information dissemination; Public health practice

Indexed keywords

EID: 77749296135     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195187410.003.0011     Document Type: Chapter

References (86)

1. American Public Health Association. APHA Media Advocacy Manual. Available at: (accessed March 5, 2006).
2. Department of Health and Human Services. Making Health Communication Programs Work (NIH Pub. No. 02-5145). Bethesda, Md.: National Cancer Institutes, 2002.
3. Hornik RC, ed. Public Health Communication: Evidence for Behavior Change. Mahwah, N.J.: Erlbaum, 2002.
4. Nelson DE, Brownson RC, Remington PL, Parvanta C, eds. Communicating Public HealthInformation Effectively. Washington, D.C.: American Public Health Association, 2002.
5. Riegelman RK. Studying a Study and Testing a Test: How to Read the Health Science Literature. 4th ed. Philadelphia, Pa.: Lippincott Williams & Wilkins, 2000.
6. Siegel, M, Doner L. Marketing Public Health: Strategies to Promote Social Change. Gaithersburg, Md.: Aspen Publishers, 1998.
7. Wallack L, Diaz I, Dorfman L, Woodruff K. News for a Change: An Advocate's Guide to Working with the Media. Thousand Oaks, Calif.: Sage, 1999.
8. Wallack L, Dorfman L, Jernigan D, Themba M. Media Advocacy and Public Health: Power for Prevention. Newbury Park, Calif.: Sage, 1993.
9. Andersen L, Remington PL, Trentham-Dietz A, Reeves M. Assessing a decade of progress in cancer control. Oncologist 2002;7(3):200-204.
10. Angell M, Kassirer JP. Clinical research-what should the public believe? New Engl J Med 1994;331:189-190.
11. Backer TE, Rogers EM, eds. Organizational Aspects of Health Campaigns: What Works? Newbury Park, Calif.: Sage, 1993.
12. Backer TE, Rogers EM, Sopory P, eds. Designing Health Campaigns: What Works? Newbury Park, Calif.: Sage, 1992.
13. Barefoot JC, Dahlstrom WG, Williams RB Jr. Hostility, CHD incidence, and total mortality: a 25-year follow-up study of 255 physicians. Psychosom Med 1983; 45:59-63.
14. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 1998;19:55-72.
15. Bier VM. On the state of the art: risk communication to the public. Reliab Engin Syst Saf 2001a;71:139-150.
16. Bier VM. On the state of the art: risk communication to decision-makers. Reliab Engin Syst Saf 2001b;71:151-157.
17. Brehony KA, Frederikson LW, Solomon LJ. Marketing principles and behavioral medicine. In LW Frederiksen, LJ Solomon, KA Brehony, eds. Marketing Health Behavior. Principles,Techniques, and Applications. New York: Plenum Press, 1984: pp. 3-22.
18. Brownson RC, Malone BR. Communicating public health information to policy makers. In Nelson DE, Brownson RC, Remington PL, Parvanta C, eds. Communicating Public Health Information Effectively. Washington, D.C.: American Public Health Association, 2002: pp. 97-114.
19. Cancer and Steroid Hormone Study Group. Oral contraceptive use and the risk of breast cancer. N Engl J Med 1986;315:405-411.
20. CDC. Increasing physical activity: a report on recommendations of the task force on community preventive services. MMWR 2001a;50(RR18):1-16.
21. CDC. Update: investigation of bioterrorism-related anthrax, 2001. MMWR 2001b; 50:1008-1010.
22. Coombs WT. Ongoing Crisis Communication: Planning, Managing, and Responding. Thousand Oaks, Calif.: Sage, 1999.
23. Covello VT. Risk perception and communication. Can J Public Health 1995;86:78-82.
24. Crano WD, Burgoon M, eds. Mass Media and Drug Prevention: Classic and Contemporary Theories and Research. Mahwah, N.J.: Erlbaum, 2002.
25. DHHS (U.S. Department of Health and Human Services). Making Health Communication Programs Work (NIH Pub. No. 02-5145). Bethesda, Md.: National Cancer Institutes, 2002.
26. Dillard JP, Pfau M. The Persuasion Handbook: Developments in Theory and Practice. Thousand Oaks, Calif.: Sage, 2002.
27. Falck F, Ricci A, Wolff MS, Godbold J, Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 1992;47:143-146.
28. Fearn-Banks K. Crisis Communications: A Casebook Approach. Mahwah, N.J.: Erlbaum, 2002.
29. Feinstein AR, Horwitz RI, Spitzer WO, Battista RN. Coffee and pancreatic cancer. The problems of etiologic research and epidemiologic case-control research. JAMA 1981;246:957-960.
30. Fischhoff B. Risk perception and communication unplugged: twenty years of process. Risk Anal 1995;15:137-145.
31. Flay BR, Burton D. Effective mass communication strategies for health campaigns. In Atkin C, Wallack L, eds. Mass Communication and Public Health: Complexities and Conflicts. Newbury Park, Calif.: Sage, 1990: pp. 129-146.
32. Frey CA, Remington PL, Lengerich E. Evaluation of the Centers for Disease Control and Prevention's Chronic Disease State-Based Epidemiology for Public Health Program Support (STEPPS) Program. J Public Health Manag Pract 2003;9(4): 266-274.
33. Friedman SM, Dunwoody S, Rogers CL, eds. Communicating Uncertainty: Media Coverage of New and Controversial Science. Mahwah, N.J.: Erlbaum, 1999.
34. Glanz K, Lewis FM, Rimer BK, eds. Health Behavior and Health Education: Theory, Research, and Practice. 2nd ed. San Francisco, Calif.: Jossey-Bass, 1997.
35. Goodman RA, Remington PL, Howard RJ. Communicating information for action within the public health system. In Teutsch SM, Churchill RE, eds. The Principles and Practice of Public Health Surveillance. 2nd ed. New York: Oxford University Press, 2000: pp. 168-176.
36. Greenwell M. Communicating public health information to the news media. In Nelson DE, Brownson RC, Remington PL, Parvanta C, eds. Communicating Public Health Information Effectively. Washington, D.C.: American Public Health Association, 2002: pp. 73-96.
37. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:917-929.
38. Hornik RC, ed. Public Health Communication: Evidence for Behavior Change. Mahwah, N.J.: Erlbaum, 2002.
39. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal-containing vaccine and autism. JAMA 2003; 290:1763-1766.
40. Institute of Medicine, Committee for the Study of the Future of Public Health. The Future of Public Health. Washington, D.C.: National Academy Press, 1988.
41. Institute of Medicine, Committee on Health Literacy. Health literacy: A Prescription to End Confusion. Washington, D.C.: National Academy Press, 2004.
42. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004; 101(1):3-27.
43. Jüni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004; 364(9446):1-9.
44. Kaufman DW, Miller DR, Rosenberg L, et al. Noncontraceptive estrogen use and risk of breast cancer. JAMA 1984;252:63-67.
45. Kotler P, Roberto N, Lee N. Social Marketing: Improving the Quality of Life. 2nd ed. Thousand Oaks, Calif.: Sage, 2002.
46. Kotler P, Zaltman G. Social marketing: an approach to planned change. J Marketing 1971;35:3-12.
47. Kreuter MW, Lezin NA, Kreuter MW, Green LW. Community Health Promotion. Ideas That Work. A Field Book for Practitioners. Sudbury, Mass.: Jones and Bartlett, 1998.
48. Kreutzer R, Arneson C. The scientific assessment and public perception of risk. Curr Issues Public Health 1995;1:102-104.
49. Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst 1994;86:589-599.
50. MacMahon B, Yen S, Trichopoulos D, Warren K, Nardi G. Coffee and cancer of the pancreas. N Engl J Med 1981;304:630-633.
51. Maibach E, Holtgrave DR. Advances in public health communication. Annu Rev Public Health 1995;16:219-238.
52. McDonough JE. Experiencing Politics: A Legislator's Stories of Government and Health Care. Berkeley, Calif.: University of California Press, 2000.
53. Miller DR, Rosenberg L, Kaufman DW, Stolley P, Warshauer ME, Shapiro S. Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol 1989;129:269-280.
54. Miller JD, Kimmel LG. Biomedical Communications: Purposes, Methods, and Strategies. San Diego, Calif.: Academic Press, 2001.
55. National Research Council. Improving Risk Communication. Washington, D.C.: National Academy Press, 1989.
56. National Research Council. Understanding Risk: Informing Decisions in a Democratic Society. Washington, D.C.: National Academy Press, 1996.
57. Nelkin D. Selling Science: How the Press Covers Science and Technology. New York: W.H. Freeman, 1995.
58. Nelson DE, Brownson RC, Remington PL, Parvanta C, eds. Communicating Public Health Information Effectively. Washington D.C.: American Public Health Association, 2002.
59. New England Journal of Medicine. Instructions to authors. N Engl J Med 1996; 335(23):1784.
60. Parvanta C, Maibach E, Arkin E, Nelson DE, Woodward J. Public health communication: a planning framework. In Nelson DE, Brownson RC, Remington PL, Parvanta C, eds. Communicating Public Health Information Effectively. Washington, D.C.: American Public Health Association, 2002: pp. 11-31.
61. Payne JG. Oral presentations. In Nelson DE, Brownson RC, Remington PL, Parvanta C, eds. Communicating Public Health Information Effectively. Washington, D.C.: AmericanPublic Health Association, 2002: pp. 141-154.
62. Phillips DP, Kanter EJ, Bednarczyk R, Tastad PL. Importance of the lay press in the transmission of medical knowledge to the scientific community. N Engl J Med 1991;325:1180-1183.
63. Remington P, Ahrens D. Communicating to private and voluntary health agencies. In Nelson DE, Brownson RC, Remington PL, Parvanta C, eds. Communicating Public Health Information Effectively. Washington, D.C.: American Public Health Association, 2002: pp. 115-126.
64. Remington PL, Riesenberg LA, Needham DL, Siegel P. Written communication. In Nelson DE, Brownson RC, Remington PL, Parvanta C, eds. Communicating Public Health Information Effectively. Washington, D.C.: American Public Health Association, 2002: pp. 127-140.
65. Remington PL, Simoes E, Brownson RC, Siegel PZ. The role of epidemiology in chronic disease prevention and health promotion programs. J Public Health Manag Prac 2003;9(4):258-265.
66. Rice RE, Atkin CK, eds. Public Communication Campaigns. 3rd ed. Thousand Oaks, Calif.: Sage, 2001.
67. Riegelman RK. Studying a Study and Testing a Test: How to Read the Health Science Literature. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2000.
68. Rimer B, Van Nevel JP, eds. Cancer risk communication: what we know and what we need to learn. J Natl Cancer Inst Monogr 1999;25:1-185.
69. Robinson TN. Reducing children's television viewing to prevent obesity: a randomized controlled trial. JAMA 1999;282:1561-1567.
70. Seale C. Media and Health. London: Sage, 2002.
71. Shekelle RB, Hulley SB, Neaton JD, et al. The MRFIT behavior pattern study. Am J Epidemiol 1985;122:559-570.
72. Shoemaker PJ, Reese SD. Mediating the Message: Theories of Influences on Mass Media Control. 2nd ed. White Plains, N.Y.: Longman; 1996.
73. Siegel M, Doner L. Marketing Public Health: Strategies to Promote a Social Change. Gaithersburg, Md.: Aspen, 1998.
74. Slater MD. Persuasion processes across receiver goals and message genres. Commun Theory 1997;7:125-148.
75. Slovic P. The Perception of Risk. London: Earthscan, 2000.
76. Steinberg KK, Thacker SB, Smith J, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991;265:1985-1990.
77. Task Force on Community Preventive Services. Available at: (accessed March 5, 2006).
78. Taubes G. Epidemiology faces its limits. Science 1995;269:164-169.
79. The ATBC Study Group. Incidence of cancer and mortality following α-tocopherol and bcarotene supplementation. A post-intervention follow-up. JAMA 2003; 290:476-485.
80. Tinker T, Vaughan E. Risk communication. In Nelson DE, Brownson RC, Remington PL, Parvanta C, eds. Communicating Public Health Information Effectively. Washington, D.C.: American Public Health Association, 2002: pp. 185-203.
81. Wallack L, Diaz I, Dorfman L, Woodruff K. News for a Change: An Advocate's Guide to Working with the Media. Thousand Oaks, Calif.: Sage, 1999.
82. Wallack L, Dorfman L, Jernigan D, Themba M. Media Advocacy and Public Health. Power for Prevention. Newbury Park, Calif.: Sage, 1993.
83. Wilkes MS, Kravitz RL. Medical research and the media. Attitudes toward public dissemination of research. JAMA 1992;268:999-1003.
84. Willett WC, Ascherio A. Trans fatty acids: are the effects only marginal? Am J Public Health 1994;84:722-724.
85. Witte K, Meyer G, Martell D. Effective Health Risk Messages: A Step-by-Step Guide. Thousand Oaks, Calif.: Sage, 2001.
86. Writing Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principle results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.